Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers.

Rawlings-Goss RA, Campbell MC, Tishkoff SA.

BMC Med Genomics. 2014 Aug 28;7:53. doi: 10.1186/1755-8794-7-53.

2.

MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.

Marino AL, Evangelista AF, Vieira RA, Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira HC, Marques MM.

BMC Cancer. 2014 Oct 2;14:739. doi: 10.1186/1471-2407-14-739.

3.

Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.

Zeng Y, Wang KX, Xu H, Hong Y.

J Cell Biochem. 2018 Feb;119(2):1558-1566. doi: 10.1002/jcb.26315. Epub 2017 Sep 7.

PMID:
28771797
4.

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y.

Cancer Res. 2009 Jul 15;69(14):5970-7. doi: 10.1158/0008-5472.CAN-09-0236. Epub 2009 Jun 30. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

5.

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J.

Clin Cancer Res. 2008 Mar 1;14(5):1340-8. doi: 10.1158/1078-0432.CCR-07-1755.

6.

Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.

Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S.

Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y.

PMID:
25087086
7.
8.

Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.

Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.

Mol Med Rep. 2015 Jul;12(1):615-22. doi: 10.3892/mmr.2015.3428. Epub 2015 Mar 4.

PMID:
25738263
9.

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

Jiang Y, Chen J, Wu J, Hu Z, Qin Z, Liu X, Guan X, Wang Y, Han J, Jiang T, Jin G, Zhang M, Ma H, Wang S, Shen H.

Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.

10.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

11.

Circulating microRNAs as biomarkers of adult Crohn's disease.

Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1038-44. doi: 10.1097/MEG.0000000000000430.

PMID:
26230660
12.

Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.

Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu H, Liu H, Chen B, Li Q, Ma X, Chen K.

Eur J Cancer Care (Engl). 2012 Mar;21(2):274-80. doi: 10.1111/j.1365-2354.2011.01308.x. Epub 2011 Nov 11.

PMID:
22074121
13.

miRNAs can be generally associated with human pathologies as exemplified for miR-144.

Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, Bauer A, Wischhusen J, Beier M, Kohlhaas J, Katus HA, Hoheisel J, Franke A, Meder B, Meese E.

BMC Med. 2014 Dec 3;12:224. doi: 10.1186/s12916-014-0224-0.

14.

Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.

Sherafatian M.

Gene. 2018 Nov 30;677:111-118. doi: 10.1016/j.gene.2018.07.057. Epub 2018 Jul 25.

PMID:
30055304
15.

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.

RNA. 2008 Nov;14(11):2348-60. doi: 10.1261/rna.1034808. Epub 2008 Sep 23.

16.

Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.

Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E, Guo W, Pu Y, Yin L.

Oncol Rep. 2013 Jan;29(1):169-76. doi: 10.3892/or.2012.2105. Epub 2012 Oct 23.

PMID:
23124769
17.

Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.

Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H.

Hum Mutat. 2009 Jan;30(1):79-84. doi: 10.1002/humu.20837.

PMID:
18634034
18.

Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.

Lin Z, Li JW, Wang Y, Chen T, Ren N, Yang L, Xu W, He H, Jiang Y, Chen X, Liu T, Liu G.

Clin Lab. 2016;62(1-2):121-8.

PMID:
27012041
19.

Identification of four potential predicting miRNA biomarkers for multiple myeloma from published datasets.

Xiang T, Hu AX, Sun P, Liu G, Liu G, Xiao Y.

PeerJ. 2017 Jan 31;5:e2831. doi: 10.7717/peerj.2831. eCollection 2017.

20.

Genetic variants of miRNA sequences and non-small cell lung cancer survival.

Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y, Shen H.

J Clin Invest. 2008 Jul;118(7):2600-8. doi: 10.1172/JCI34934.

Supplemental Content

Support Center